Harnessing the Power of Artificial Intelligence

Zelia M. Correa; T. Y.Alvin Liu

doi:10.1007/978-3-031-08250-4_25

Harnessing the Power of Artificial Intelligence

Zelia M. Correa, T. Y.Alvin Liu

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Artificial intelligence (AI) in the form of deep learning has generated immense interest in the medical field in recent years. The application of artificial intelligence in ophthalmology has been mainly concentrated on the diseases with a high incidence, such as diabetic retinopathy, age-related macular degeneration, and glaucoma among others. AI-assisted automated screening and diagnosis of certain diseases in ophthalmology may maximize the physicians’ role at the clinic and offer the patients increased access to medical decision-making and eye care where ophthalmologists are not available. Although there are fewer initiatives in ocular oncology due to the rarity of eye tumors, the small number of specialists supports the need and immediate application of algorithms to aid screening and management decision.

Original language	English (US)
Title of host publication	Global Perspectives in Ocular Oncology
Publisher	Springer International Publishing
Pages	241-244
Number of pages	4
ISBN (Electronic)	9783031082504
ISBN (Print)	9783031082498
DOIs	https://doi.org/10.1007/978-3-031-08250-4_25
State	Published - Jan 1 2023

Keywords

Artificial intelligence
Cytology
Deep learning
Eye tumors
Fundus photographs
Optical coherence tomography
Pattern recognition

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-031-08250-4_25

Cite this

@inbook{3cb4ffcc79bd4b17a5700000c0540859,

title = "Harnessing the Power of Artificial Intelligence",

abstract = "Artificial intelligence (AI) in the form of deep learning has generated immense interest in the medical field in recent years. The application of artificial intelligence in ophthalmology has been mainly concentrated on the diseases with a high incidence, such as diabetic retinopathy, age-related macular degeneration, and glaucoma among others. AI-assisted automated screening and diagnosis of certain diseases in ophthalmology may maximize the physicians{\textquoteright} role at the clinic and offer the patients increased access to medical decision-making and eye care where ophthalmologists are not available. Although there are fewer initiatives in ocular oncology due to the rarity of eye tumors, the small number of specialists supports the need and immediate application of algorithms to aid screening and management decision.",

keywords = "Artificial intelligence, Cytology, Deep learning, Eye tumors, Fundus photographs, Optical coherence tomography, Pattern recognition",

author = "Correa, {Zelia M.} and Liu, {T. Y.Alvin}",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.",

year = "2023",

month = jan,

day = "1",

doi = "10.1007/978-3-031-08250-4_25",

language = "English (US)",

isbn = "9783031082498",

pages = "241--244",

booktitle = "Global Perspectives in Ocular Oncology",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Harnessing the Power of Artificial Intelligence

AU - Correa, Zelia M.

AU - Liu, T. Y.Alvin

N1 - Publisher Copyright: © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Artificial intelligence (AI) in the form of deep learning has generated immense interest in the medical field in recent years. The application of artificial intelligence in ophthalmology has been mainly concentrated on the diseases with a high incidence, such as diabetic retinopathy, age-related macular degeneration, and glaucoma among others. AI-assisted automated screening and diagnosis of certain diseases in ophthalmology may maximize the physicians’ role at the clinic and offer the patients increased access to medical decision-making and eye care where ophthalmologists are not available. Although there are fewer initiatives in ocular oncology due to the rarity of eye tumors, the small number of specialists supports the need and immediate application of algorithms to aid screening and management decision.

AB - Artificial intelligence (AI) in the form of deep learning has generated immense interest in the medical field in recent years. The application of artificial intelligence in ophthalmology has been mainly concentrated on the diseases with a high incidence, such as diabetic retinopathy, age-related macular degeneration, and glaucoma among others. AI-assisted automated screening and diagnosis of certain diseases in ophthalmology may maximize the physicians’ role at the clinic and offer the patients increased access to medical decision-making and eye care where ophthalmologists are not available. Although there are fewer initiatives in ocular oncology due to the rarity of eye tumors, the small number of specialists supports the need and immediate application of algorithms to aid screening and management decision.

KW - Artificial intelligence

KW - Cytology

KW - Deep learning

KW - Eye tumors

KW - Fundus photographs

KW - Optical coherence tomography

KW - Pattern recognition

UR - http://www.scopus.com/inward/record.url?scp=85158940515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85158940515&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-08250-4_25

DO - 10.1007/978-3-031-08250-4_25

M3 - Chapter

AN - SCOPUS:85158940515

SN - 9783031082498

SP - 241

EP - 244

BT - Global Perspectives in Ocular Oncology

PB - Springer International Publishing

ER -

Harnessing the Power of Artificial Intelligence

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this